CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Hematology in community medical care.
Hematology in community medical care.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
社区医疗面临医师分布不均、医疗需求波动以及医学领域专业化程度提高导致对医师的相对需求增加等挑战。血液科医师主要处理提示血液系统疾病的问题,如血细胞计数异常、淋巴结肿大、持续发热和凝血异常。然而,社区医学中对血液系统疾病治疗的重视程度仍然相对较低。在检验技师配合和人工智能支持下,对血液系统疾病进行准确可靠的鉴别和识别是必要的。血液系统疾病的治疗已取得重大进展;然而,小型社区医院往往无法获得这些治疗,也无法开展需要CAR-T 细胞疗法等专业设备的临床试验。未来,血液科医师需要专注于在社区中发展自己的职业,并进一步优化其实践以提升患者照护。J. Med. Invest. 72 : 21-25, February, 2025.
Community medical care faces challenges such as the uneven distribution of physicians, fluctuating medical demand, and the increased relative demand for physicians due to the increased specialization of medical fields. Hematologists primarily address issues, such as abnormal blood cell counts, lymphadenopathy, persistent fever, and coagulation abnormalities, which indicate hematological diseases.
However, the emphasis on treating hematologic diseases within community medicine remains relatively low. Accurate and reliable differentiation and identification of hematological diseases with the cooperation of laboratory technicians and support of artificial intelligence is necessary.
Significant advances have been made in the treatment of hematological diseases; however, small community hospitals often lack access to these treatments and are unable to conduct clinical trials that require specialized equipment such as for chimeric antigen receptor T-cell therapy. In the future, hematologists will need to focus on developing their careers within the community and further optimizing their practice to enhance patient care. J. Med. Invest. 72 : 21-25, February, 2025.
MEMBER ACCOUNT
登录成功会直接打开下一页。